Suppr超能文献

阿尔茨海默病神经病理变化与认知状态的相关性:文献综述。

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

机构信息

Sanders-Brown Center on Aging, Department of Pathology, University of Kentucky, Lexington 40536-0230, USA.

出版信息

J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.

Abstract

Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research. Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations. Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes. Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD. Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways. We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment. We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles. Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.

摘要

临床病理相关性研究对于阿尔茨海默病(AD)研究领域至关重要。对经过尸检证实的人类受试者进行的研究存在许多潜在的偏倚,这些偏倚会影响研究的普遍适用性和相关性的有效性。许多数据变异性来源可能会削弱认知状态与 AD 神经病理变化之间的明显相关性。事实上,大多数高龄人群都有明显的非 AD 脑损伤,这些损伤可能会独立于 AD 改变认知。全球范围内的研究工作已经评估了数千名人类受试者,以评估老年人认知障碍的原因,这些研究已经以不同的方式进行了解读。我们回顾了文献,重点关注 AD 神经病理变化(即β-淀粉样斑块和神经纤维缠结)与认知障碍的相关性。我们讨论了在老年人中观察到的各种大脑变化模式,以提供理解 AD 临床病理相关性的视角,并得出结论,来自许多独立研究中心的证据强烈支持特定疾病的存在,该疾病的定义是存在 Aβ斑块和神经纤维缠结。虽然 Aβ 斑块可能在 AD 的发病机制中起关键作用,但认知障碍的严重程度与新皮质神经纤维缠结的负担相关性最好。

相似文献

1
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.
3
Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.
J Neuropathol Exp Neurol. 2009 Jan;68(1):1-14. doi: 10.1097/NEN.0b013e3181919a48.
6
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Neurology. 2005 Mar 8;64(5):834-41. doi: 10.1212/01.WNL.0000152982.47274.9E.
7
Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
JAMA Neurol. 2019 Jul 1;76(7):818-826. doi: 10.1001/jamaneurol.2019.0834.

引用本文的文献

1
Twenty years of therapeutic development in tauopathy mouse models: a scoping review.
Alzheimers Dement. 2025 Aug;21(8):e70578. doi: 10.1002/alz.70578.
2
Divergent effects of age on imaging-based ATN biomarkers and cognition in Alzheimer's disease.
Alzheimers Dement (Amst). 2025 Aug 11;17(3):e70142. doi: 10.1002/dad2.70142. eCollection 2025 Jul-Sep.
3
Bridging the molecular and clinical aspects of resveratrol in Alzheimer's disease: a review.
3 Biotech. 2025 Sep;15(9):284. doi: 10.1007/s13205-025-04451-x. Epub 2025 Aug 6.
4
The first 25 years of the Northwestern University SuperAging Program.
Alzheimers Dement. 2025 Aug;21(8):e70312. doi: 10.1002/alz.70312.
5
Cognitive impairment and p-tau217 are high in a vascular patient cohort.
Alzheimers Dement. 2025 Aug;21(8):e70565. doi: 10.1002/alz.70565.
7
9
Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer's disease.
Transl Neurodegener. 2025 Jul 29;14(1):39. doi: 10.1186/s40035-025-00499-0.

本文引用的文献

1
Neuropathology and general autopsy findings in nondemented aged subjects.
Clin Neuropathol. 2012 Mar-Apr;31(2):87-98. doi: 10.5414/np300418.
2
Neocortical and hippocampal amyloid-β and tau measures associate with dementia in the oldest-old.
Brain. 2011 Dec;134(Pt 12):3708-15. doi: 10.1093/brain/awr308. Epub 2011 Nov 26.
5
Aβ-degrading enzymes: potential for treatment of Alzheimer disease.
J Neuropathol Exp Neurol. 2011 Nov;70(11):944-59. doi: 10.1097/NEN.0b013e3182345e46.
6
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.
8
Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
Acta Neuropathol. 2011 Nov;122(5):577-89. doi: 10.1007/s00401-011-0871-6. Epub 2011 Sep 21.
9
Resolving controversies on the path to Alzheimer's therapeutics.
Nat Med. 2011 Sep 7;17(9):1060-5. doi: 10.1038/nm.2460.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验